Orig3n Expands Globally with Funding from Haitong International, International Tech Conference Partnerships

BOSTON, July 11, 2018 /PRNewswire/ -- Orig3n, a Boston-based biotech research company pioneering the future of health through genetics and regenerative medicine, today announced the initial close of Series B financing with Haitong......
. .
Veröffentlicht von: Finanzen.at - Nachrichten Ticker - Wednesday, 11 July

Share |